Project Grant R21MH143037
- The National Institute of Mental Health awarded the University of Georgia Research Foundation, Inc. $405,505 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate how daily social media engagement influences mood and coping among socially disconnected adolescents in rural and low-resource areas. The research comprises two stages. Stage 1 will collect one month of passive mobile-use data from 20 rural adolescents ages 13–17 to derive preliminary...
- The National Institute of Mental Health awarded Northwestern University $188,499 under the Mental Health Research Grants program (CFDA 93.242) on July 24, 2026, to adapt digital single-session interventions for delivery by lay providers in rural high schools. The project focuses on addressing barriers to mental health care for adolescents with depression in rural communities, where internalizing problems are more prevalent yet mental health providers and treatment options are scarce. The...
- The National Institute of Mental Health awarded the University of Colorado $430,163 on March 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to validate and translate a smartphone-based intervention monitoring approach (SBIM) for adolescents with mood disorders. The project develops a low-burden monitoring strategy to improve adherence to inter-session behavioral and mood tracking in adolescent mental health interventions. Study participants (N=33, ages 13–19 years)...
- The National Institute of Mental Health awarded the University of California, San Diego $2.115 million on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a mobile health system delivering just-in-time adaptive interventions based on dialectical behavior therapy principles for young adults with comorbid major depressive disorder, social anxiety disorder, generalized anxiety disorder, and related anxiety conditions. The UNDERSTAND project...
- The National Institute of Mental Health awarded Emory University $182,693 on June 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to validate and optimize a mobile application for capturing speech-based biomarkers associated with major depressive disorder in a community sample. Dr. Kaplan, an Assistant Professor at Emory University School of Medicine, is developing the "FABLA" mobile app—originally piloted with funding from the Georgia CTSA—to assess speech...
- The National Institute of Mental Health awarded Miresource, Inc. $1.744 million on September 12, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop a longitudinal mental health monitoring platform that generates personalized care guides and treatment referrals. Miresource will integrate software solutions, curate mental health content, and employ artificial intelligence to create personalized guides and automate triage and referral recommendations. The project aims to...
- The National Institute of Mental Health awarded Georgia TECH Research Corp $2.596 million on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop multiscale models for analyzing multi-animal social interactions and decision-making. The research project, running through March 31, 2030, will develop methods to break down complex multi-animal behaviors into fundamental units and examine how those units combine to form higher-order social behaviors. Work...
- The National Institute of Mental Health awarded The Rand Corporation $676,820 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to evaluate the decentralization and scale-up of integrated chronic care clinics in Malawi. The award funds a stepped-wedge cluster randomized trial that would permanently transition Malawi's HIV delivery platform—a network of 700 clinics serving over 900,000 clients—into full-time integrated chronic care facilities providing daily...
- The National Institute of Mental Health awarded Beth Israel Deaconess Medical Center, Inc. $2.961 million on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop standardized digital health data formats for mental health research and clinical care. The award funds five integrated aims. Aim 1 establishes a multidisciplinary consortium of clinicians, researchers, industry representatives, regulators, and patient advocates to develop a governance framework...
- The National Institute of Mental Health awarded the University of Wisconsin - Madison $747,342 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct an examination of social connection in suicide risk during the college transition. The project leverages multimodal, high-resolution assessments to elucidate how social connection across digital and physical contexts contributes to suicide risk during the transition to college. The research will collect...
The National Institute of Mental Health awarded the University of Georgia Research Foundation, Inc. $415,250 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to assess mental health needs and service access barriers among socially disconnected young adults aged 18–25 in rural areas of the Southern United States. The project leverages geosocial network applications to engage young adults not currently receiving outpatient mental health care and employs ecological momentary assessment—a real-time smartphone-based data collection method—to monitor daily stressors, coping behaviors, and mental health fluctuations. Aim 1 identifies measurable barriers to outpatient mental health service utilization and optimizes recruitment strategies through 20 semi-structured interviews examining digital engagement patterns, prior service use, and perceived barriers to care. Aim 2 assesses the feasibility of smartphone-delivered assessment to monitor mental health in real time, recruiting 150 participants and collecting both validated symptom scales and passive device-based behavioral indicators on stress, anxiety, depression, substance use, and coping behaviors. Performance occurs in Athens, Georgia. The period of performance runs from August 1, 2026, through July 31, 2028. This assistance is classified as a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $415.3k | 7/29/26 |